Jun 15, 2023 4:45 pm EDT NeoGenomics' RaDaR Assay for Minimal Residual Disease Receives First Commercial Coverage
Jun 5, 2023 7:00 am EDT NeoGenomics and German Breast Group Announce New Data Demonstrating Clinical Potential of the RaDaR MRD Assay in HR+/HER2- Breast Cancer
Jun 1, 2023 7:00 am EDT NeoGenomics to Participate at the Goldman Sachs 44th Annual Global Healthcare Conference
May 30, 2023 7:00 am EDT NeoGenomics to Showcase the Transformational Impact of RaDaR(R) Assay for Molecular Residual Disease and Recurrence Monitoring at ASCO
Apr 11, 2023 7:00 am EDT NeoGenomics to Participate at the 22nd Annual Needham Virtual Healthcare Conference
Apr 6, 2023 7:00 am EDT NeoGenomics to Share Nine Abstracts at the American Association of Cancer Research (AACR) Annual Meeting 2023
